Big Gain For Genprex, Inc.
Tue, Nov 19, 2019 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) soared today at $0.62, representing a gain of 48.9%. On Mon, 18 Nov 19, GNPX:NASDAQ touched a New 2-Week Low of $0.39. The stock appeared on our News Catalysts scanner on Tue, 19 Nov 19 at 08:51 AM. From Tue, 29 Oct 19, the stock recorded 21.43% Up Days and 20.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Myovant Sciences Ltd. (MYOV:NYSE), 113.2%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 80.92%
- Genprex, Inc. (GNPX:NASDAQ), 48.93%
- Athenex, Inc. (ATNX:NASDAQ), 35.66%
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 29.2%
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 29.16%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 28.43%
- Heat Biologics, Inc. (HTBX:NASDAQ), 26.22%
- Avinger, Inc. (AVGR:NASDAQ), 25.49%
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 25.03%